LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Inicio・Lista de Acciones・Arcus Biosciences Inc

Arcus Biosciences Inc

Cerrado

Sector Salud

18.29 2.75

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

17.67

Máximo

18.4

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+82.92 upside

Dividendos
By Dow Jones
Próximas Ganancias	5 nov 2024

Noticias sobre sentimiento de mercado

By Acuity

43%

57%

172 / 366 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

17.9 / 18.37 Soporte y Resistencia

Arcus Biosciences Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

17 oct 2024, 23:57 UTC

Acciones populares

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

17 oct 2024, 22:35 UTC

Adquisiciones, fusiones, absorciones

SLB to Sell Interest in Palliser Block in Canada

17 oct 2024, 21:33 UTC

Ganancias

Principales Movimientos del Mercado

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17 oct 2024, 20:56 UTC

Ganancias

Intuitive Surgical Posts 3Q Revenue Growth

17 oct 2024, 23:51 UTC

Charlas de Mercado

BHP Unlikely to Quickly Approach Anglo American Again, Says Bull -- Market Talk

17 oct 2024, 23:22 UTC

Principales Noticias

Amex Earnings Will Test Stock's Rally. Revenue Is the Focus. -- Barrons.com

17 oct 2024, 23:14 UTC

Principales Noticias

Ganancias

Netflix Subscriber Growth Slows Amid Revenue Gains -- 4th Update

17 oct 2024, 22:56 UTC

Charlas de Mercado

Santos's Balance Sheet Risks to Ease From Here -- Market Talk

17 oct 2024, 22:52 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Santos's Upcoming Investor Day Likely Positive -- Market Talk

17 oct 2024, 22:32 UTC

Charlas de Mercado

De Grey Runs Into Delay on Hemi Permitting, But Approval Likely -- Market Talk

17 oct 2024, 22:23 UTC

Charlas de Mercado

Nike Outlook Revised on Unclear Outcome of Turnaround Strategy -- Market Talk

17 oct 2024, 22:13 UTC

Charlas de Mercado

Ganancias

Global Equities Roundup: Market Talk

17 oct 2024, 22:13 UTC

Charlas de Mercado

Ganancias

Netflix Isn't Interested in Bundling With Other Streaming Services -- Market Talk

17 oct 2024, 21:57 UTC

Principales Noticias

Ganancias

Netflix Subscriber Growth Slows Amid Revenue Gains -- 3rd Update

17 oct 2024, 21:48 UTC

Adquisiciones, fusiones, absorciones

SLB: Palliser Block Consists of Oil and Gas Wells, Surface Facilities, a Pipeline Network and Certain Oil and Gas Development Rights >SLB

17 oct 2024, 21:48 UTC

Adquisiciones, fusiones, absorciones

SLB: Transaction Is Expected to Close Late in the 4Q >SLB

17 oct 2024, 21:48 UTC

Adquisiciones, fusiones, absorciones

SLB: Announces Definitive Agreement to Sell Its Interests in Palliser Block

17 oct 2024, 21:32 UTC

Charlas de Mercado

Ganancias

Netflix's Release Schedule Should be 'Largely Back to Normal' in 2025 -- Market Talk

17 oct 2024, 21:25 UTC

Principales Noticias

Google Executive Overseeing Search and Advertising Leaves Role -- 2nd Update

17 oct 2024, 21:21 UTC

Charlas de Mercado

Ganancias

Netflix Says It Will Double Revenue from Advertising in FY25 -- Market Talk

17 oct 2024, 21:18 UTC

Ganancias

Principales Movimientos del Mercado

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

17 oct 2024, 21:10 UTC

Principales Noticias

Ganancias

Lucid Stock Tumbles 18%. EV Maker Plans Huge Share Sale, Sees Wider Losses. -- Barrons.com

17 oct 2024, 21:03 UTC

Adquisiciones, fusiones, absorciones

CSX, Canadian Pacific Kansas City, Genesee & Wyoming: Surface Transportation Board Approves CSX, CPKC Respective Applications Regarding Acquisition of Rail Lines Operated by G&W's Meridian & Bigbee Railroad

17 oct 2024, 20:55 UTC

Ganancias

Netflix Clobbers Third-Quarter Estimates, Guides Above Views -- IBD

17 oct 2024, 20:55 UTC

Ganancias

Netflix Stock Jumps on a Strong Outlook for Profit Margin. Prices Are Going Up Across the World. -- Barrons.com

17 oct 2024, 20:50 UTC

Ganancias

Netflix Stock Jumps on a Strong Outlook for Profit Margin. Prices Are Growing Up Across the World. -- Barrons.com

17 oct 2024, 20:50 UTC

Charlas de Mercado

Ganancias

Auto & Transport Roundup: Market Talk

17 oct 2024, 20:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

17 oct 2024, 20:50 UTC

Charlas de Mercado

Ganancias

Basic Materials Roundup: Market Talk

17 oct 2024, 20:49 UTC

Principales Noticias

Ganancias

Netflix Subscriber Growth Slows Amid Revenue Gains -- 2nd Update

Comparación entre iguales

Cambio de precio

Arcus Biosciences Inc Esperado

Precio Objetivo

By TipRanks

82.92% repunte

Estimación a 12 meses

Media 32.67 USD 82.92%

Máximo 46 USD

Mínimo 22 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Arcus Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

Comprar

Mantener

Vender

De acuerdo con 7 analistas que ofrecen calificaciones bursátiles a para Arcus Biosciences Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

17.9 / 18.37Soporte y Resistencia

Bullish events outweigh bearish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentimiento

By Acuity

172 / 366 Clasificación en Salud

Finanzas

Otras acciones del sector

LLY

Eli Lilly and Co.

916.07

↓-0.02%

UNH

UnitedHealth Group Inc

566.13

↓-0.87%

NVO

Novo Nordisk A-S

118.17

↑ +0.23%

JNJ

Johnson and Johnson

164.55

↑ +0.16%

ABBV

AbbVie Inc

188.57

↓-1%

Arcus Biosciences Inc

Resumen

Variación precio

Recomendaciones

Dividendos

Noticias sobre sentimiento de mercado

Puntuación técnica

Arcus Biosciences Inc Gráfico

Noticias Relacionadas

Comparación entre iguales

Arcus Biosciences Inc Esperado

Precio Objetivo

Consenso

Puntuación técnica

Sentimiento

Finanzas

Otras acciones del sector

Crucial information about Facebook accounts